Greg Sivanovich
Analyst
Analyst — Mizuho Securities
Earnings-call appearances
-
Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL5012025-08-27
BioXcel Therapeutics, Inc. (BTAI)